ES8802610A1 - Un metodo para preparar un compuesto quimico, inhibidor de las 5-lipoxigenasas,util para la terapia humana y veterinaria - Google Patents

Un metodo para preparar un compuesto quimico, inhibidor de las 5-lipoxigenasas,util para la terapia humana y veterinaria

Info

Publication number
ES8802610A1
ES8802610A1 ES552805A ES552805A ES8802610A1 ES 8802610 A1 ES8802610 A1 ES 8802610A1 ES 552805 A ES552805 A ES 552805A ES 552805 A ES552805 A ES 552805A ES 8802610 A1 ES8802610 A1 ES 8802610A1
Authority
ES
Spain
Prior art keywords
hydrogen
alkyl
formula
compounds
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES552805A
Other languages
English (en)
Other versions
ES552805A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858506094A external-priority patent/GB8506094D0/en
Priority claimed from GB858525153A external-priority patent/GB8525153D0/en
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Publication of ES552805A0 publication Critical patent/ES552805A0/es
Publication of ES8802610A1 publication Critical patent/ES8802610A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C07D213/34—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Abstract

LOS DERIVADOS ARIL SUSTITUIDOS DE PRIRIDINA O QUINOLINA (I), DONDE NO EXCLUSIVAMENTE, X ES OXIGENO O AZUFRE, R1 Y R2 SON ALQUILO C1-8, R3, R4, R5 Y R6, HALOGENO, CIANO O NITRO, PUDIENDO R5 Y R6 FORMAR UN ANILLO AROMATICO FUSIONADO CON EL PIRIDILO; SE OBTIENEN HACIENDO REACCIONAR UN COMPUESTO (II) CON OTRO R2Y, SIENDO Y <<UN GRUPO DE BUENA SALIDA>> TAL COMO HALOGENO O ALQUIL-, Y POSTERIORMENTE CON OTRO COMPUESTO R1Y, EN UN DISOLVENTE INERTE COMO LA DIMETILFROMAMIDA, EN PRESENCIA DE UNA BASE OPCIONAL EL CARBONATO POTASICO Y ENTRE TEMPERATURA AMBIENTE Y LA DE REFLUJO. INHIBEN LA 5-LIPOXIGENASA, POR LO QUE ES APLICABLE A LA TERAPIA DE ASMA, ALERGIA, ARTRITIS REUMATICA, ARTEROESCLEROSIS, PSORIASIS Y OTRAS SITUACIONES INFLAMATORIAS. *FORMULA*
ES552805A 1985-03-08 1986-03-07 Un metodo para preparar un compuesto quimico, inhibidor de las 5-lipoxigenasas,util para la terapia humana y veterinaria Expired ES8802610A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858506094A GB8506094D0 (en) 1985-03-08 1985-03-08 Chemical products
GB858525153A GB8525153D0 (en) 1985-10-11 1985-10-11 Chemical compounds

Publications (2)

Publication Number Publication Date
ES552805A0 ES552805A0 (es) 1988-09-16
ES8802610A1 true ES8802610A1 (es) 1988-09-16

Family

ID=26288945

Family Applications (1)

Application Number Title Priority Date Filing Date
ES552805A Expired ES8802610A1 (es) 1985-03-08 1986-03-07 Un metodo para preparar un compuesto quimico, inhibidor de las 5-lipoxigenasas,util para la terapia humana y veterinaria

Country Status (18)

Country Link
US (2) US4826987A (es)
JP (1) JPH0764813B2 (es)
AU (1) AU585586B2 (es)
BE (1) BE904368A (es)
CA (1) CA1276640C (es)
DE (1) DE3607382A1 (es)
DK (1) DK166582B1 (es)
ES (1) ES8802610A1 (es)
FR (1) FR2578540B1 (es)
GB (1) GB2173788B (es)
GR (1) GR860628B (es)
IE (1) IE58870B1 (es)
IT (1) IT1221079B (es)
LU (1) LU86349A1 (es)
NL (1) NL8600596A (es)
NZ (1) NZ215347A (es)
PT (1) PT82147B (es)
SE (1) SE463819B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE68789T1 (de) * 1985-10-16 1991-11-15 Merck Frosst Canada Inc 2-substituierte chinoline.
DK196688A (da) * 1987-04-28 1988-10-29 Fujisawa Pharmaceutical Co Bicykliske forbindelser og fremgangsmaade til fremstilling deraf
US4826990A (en) * 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
GB8728051D0 (en) * 1987-12-01 1988-01-06 Leo Pharm Prod Ltd Chemical compounds
US4889935A (en) * 1987-12-18 1989-12-26 American Home Products Corporation Aminoguanidine derivatives
US5248685A (en) * 1989-04-07 1993-09-28 Pfizer Inc. Substituted 1-[3-(heteroarylmethoxy)phenyl]alkanols and related compounds in the treatment of asthma
DE3927369A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe
DE3935139A1 (de) * 1989-10-21 1991-04-25 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-thioharnstoffe
US5021576A (en) * 1989-10-27 1991-06-04 American Home Products Corporation 2-Anilino phenylacetic acid derivatives
US5324747A (en) * 1992-07-15 1994-06-28 Hoffmann-La Roche Inc. N-substituted anilines, inhibitors of phospholipases A2
US7189834B2 (en) * 1993-05-11 2007-03-13 Marshall William E Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
US5508408A (en) * 1993-09-10 1996-04-16 Ciba-Geigy Corporation Quinoline compound
US5795900A (en) * 1995-10-03 1998-08-18 Abbott Laboratories Symmetrical bis-heteroaryl-methoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
US5668150A (en) * 1996-07-26 1997-09-16 Abbott Laboratories Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
ATE261730T1 (de) * 1997-12-31 2004-04-15 Univ Kansas Wasserlösliche medikamentenvorstufen tertiärer amine enthaltender medikamente und verfahren zu ihrer herstellung
HN2001000008A (es) 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) * 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) * 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
TW200920369A (en) * 2007-10-26 2009-05-16 Amira Pharmaceuticals Inc 5-lipoxygenase activating protein (flap) inhibitor
CN102137858B (zh) * 2008-05-23 2014-07-23 潘米拉制药有限责任公司 5-脂氧合酶-活化蛋白抑制剂
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
TW201215607A (en) 2010-07-02 2012-04-16 Lundbeck & Co As H Aryl-and heteroarylamid derivatives as PDE10A enzyme inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31624A (en) * 1861-03-05 Tatting-frame
US2761865A (en) * 1954-07-07 1956-09-04 Hoffmann La Roche Pyridylalkyl sulfones
US4003906A (en) * 1974-01-22 1977-01-18 The Dow Chemical Company Substituted pyridinyl methylthio or (methylsulfonyl)benzeneamines
GB2069492B (en) * 1980-02-20 1984-02-29 Wyeth John & Brother Ltd Sulphur compounds
GB2069493B (en) * 1980-02-20 1984-02-29 Wyeth John & Brother Ltd Pyridine derivatives
US4567184A (en) * 1982-12-01 1986-01-28 Usv Pharmaceutical Corporation Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds
JPS5988835U (ja) * 1982-12-06 1984-06-15 ホシデン株式会社 スイツチ
US4486593A (en) * 1983-01-19 1984-12-04 The Upjohn Company 2-,3-, or 4-Pyridinylmethylamino arylic acids as thromboxane A2 synthetase and 5-lipoxygenase inhibitors
US4563463A (en) * 1983-03-18 1986-01-07 Usv Pharmaceutical Corp. 2-Oxo-1,3-oxazolo[4,5-h] quinolines useful as anti-allergy agents
US4554355A (en) * 1984-07-19 1985-11-19 American Home Products Corporation Heterocyclic compounds as antiallergic agents
US5109009A (en) * 1985-03-08 1992-04-28 Leo Pharmaceutical Products Ltd. Quinoline and pyridine compounds and inhibition of 5-lipoxygenases therewith

Also Published As

Publication number Publication date
IT1221079B (it) 1990-06-21
BE904368A (fr) 1986-09-08
GB2173788B (en) 1988-08-10
AU5444486A (en) 1986-09-18
DE3607382A1 (de) 1986-09-11
NL8600596A (nl) 1986-10-01
US5157039A (en) 1992-10-20
DK96986A (da) 1986-09-09
GB2173788A (en) 1986-10-22
SE8600913D0 (sv) 1986-02-28
GR860628B (en) 1986-06-26
PT82147B (pt) 1988-07-29
FR2578540B1 (fr) 1990-11-16
IE860370L (en) 1986-09-08
AU585586B2 (en) 1989-06-22
US4826987A (en) 1989-05-02
FR2578540A1 (fr) 1986-09-12
GB8604183D0 (en) 1986-03-26
IT8667183A0 (it) 1986-03-06
JPS61207374A (ja) 1986-09-13
IE58870B1 (en) 1993-11-17
JPH0764813B2 (ja) 1995-07-12
DK166582B1 (da) 1993-06-14
LU86349A1 (fr) 1987-04-02
PT82147A (en) 1986-04-01
NZ215347A (en) 1990-02-26
ES552805A0 (es) 1988-09-16
SE463819B (sv) 1991-01-28
CA1276640C (en) 1990-11-20
DK96986D0 (da) 1986-03-04
SE8600913L (sv) 1986-09-09

Similar Documents

Publication Publication Date Title
ES8802610A1 (es) Un metodo para preparar un compuesto quimico, inhibidor de las 5-lipoxigenasas,util para la terapia humana y veterinaria
GR3017850T3 (en) Pyrazolopyridine compound and processes for preparation thereof.
ES8103744A1 (es) Un metodo para la preparacion de derivados de ftalimidina
EP0145340A3 (en) 1h-imidazoû4,5-c¨quinolines and 1h-imidazoû4,5-c¨quinolin-4-amines
AU3926295A (en) Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
HUP0100615A2 (hu) Szubsztituált 2-(2,6-dioxo-3-fluoro-piperidin-3-il)-izoindolinok és ezek alkalmazása TNFalfa-szint csökkentésére
KR850001171A (ko) 퀴놀린 화합물의 제조방법
HUP0203294A2 (hu) Benzodiazepinszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NZ227003A (en) Quinoline derivatives and pharmaceutical compositions containing such
DE3167774D1 (en) 4-substituted-2-oxoazetidine compounds, processes for their preparation, and their use for preparing antibiotics
LV10254B (en) Mixture of quinolinecarboxylic acid and boric acid anhydride as intermediate derivatives of piperazinyl-3-quinolincarboxylic acid with antibacterial activity
ES8303427A1 (es) &#34;un procedimiento para preparar compuestos de cefem&#34;.
NZ204969A (en) 5-(lower alkyl)-1,6-naphthyridine-2(1h)-one derivatives and pharmaceutical compositions containing such
RU95101437A (ru) Содержащее производные 3-фенилсульфонил-3,7-диазабицикло [3,3,1] нонана лекарственное средство, способ получения производных 3-фенилсульфонил-3,7-диазабицикло-[3,3,1]-нонана
TW350838B (en) Quinoline derivatives
ES8801637A1 (es) Un procedimiento para la preparacion de benzimidazoles.
IE820078L (en) Quinolones
HUP0204572A2 (en) Substituierte bisindolylmaleinimide derivatives, process for their preparation and use and pharmaceutcial compositions containing them
HUP0300392A2 (hu) Benzo[a]fenazin-11-karboxamid-származékok és alkalmazásuk közös topoizomeráz I és II inhibitor hatású gyógyszerkészítmények előállítására, eljárás az előállításukra és intermedierjeik
IL60176A0 (en) Xanthine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
ES8304956A1 (es) Un procedimiento para preparar nuevos derivados de 1,4-benzotiazina.
DK35387D0 (da) Quinolinderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende derivaterne
DE3167186D1 (en) Substituted pyrimidin-2-ones, the salts thereof, processes for their preparation, pharmaceutical compositions containing them and a method therefor
ES8307798A1 (es) Un procedimiento para la preparacion de derivados de piperazilmetil-4-dibenzofuranona, o, dibenzofuranol.
AU5814386A (en) Substituted pyridine-1-oxides

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990405